Etoricoxib
Osteoarthritis is a disease that affects the joints. It occurs as a result of the gradual breakdown of cartilage lining the ends of bones. This causes swelling (inflammation), pain, tenderness, stiffness, and disability.
Rheumatoid arthritis is a long-lasting inflammatory disease of the joints. It causes pain, stiffness, swelling, and limited mobility of the affected joints. It also causes inflammation in other parts of the body.
Gout is a disease characterized by sudden, recurring attacks of very painful inflammation and redness of the joints. This disease is caused by the deposition of crystalline deposits in the joint.
Ankylosing spondylitis is an inflammatory disease of the spine and large joints.
In the event of any of the above situations, you should consult your doctor before taking the tablets.
Before starting to take Coxydyna, you should discuss it with your doctor or pharmacist:
In case of doubt as to whether any of the above situations apply, you should consult your doctor before taking Coxydynato clarify whether the medicine can be taken.
Coxydyna is equally effective in both elderly and younger adult patients. In patients over 65 years of age, the doctor may decide on more frequent check-ups. No dose adjustment is necessary for patients over 65 years of age.
Do not give this medicine to children and adolescents under 16 years of age.
Tell your doctor or pharmacist about all medicines you are taking now or have recently taken, as well as any medicines you plan to take, including those available without a prescription.
In the case of taking one of the following medicines, your doctor may decide to monitor you to ensure that the treatment is going well from the start of taking Coxydyna:
while taking Coxydyna.
The effect of the medicine may start faster if Coxydyna is taken on an empty stomach.
Pregnancy
Coxydyna should not be taken by pregnant women. A pregnant woman or a woman who may be pregnant or is planning to become pregnant should not take this medicine. If you become pregnant, stop taking the medicine and contact your doctor. If you have any doubts or need further information, consult your doctor.
Breastfeeding
It is not known whether Coxydyna is excreted in breast milk. If you are breastfeeding or planning to breastfeed, consult your doctor before taking Coxydyna. If you are taking Coxydyna, do not breastfeed.
Fertility
It is not recommended to take Coxydyna in women planning to become pregnant.
Some patients taking this medicine have reported dizziness and drowsiness. Do not drive vehicles, if you experience dizziness and drowsiness.
Do not operate any machinery or use tools, if you experience dizziness and drowsiness.
This medicine should always be taken as directed by your doctor. If you have any doubts, consult your doctor or pharmacist.
Do not take higher doses than recommended for individual diseases. From time to time, you should consult your doctor to monitor the treatment. It is important to use the smallest effective dose that provides pain relief and not to take Coxydyna for longer than necessary. There is an increased risk of heart attacks and strokes with prolonged use of the medicine, especially in high doses.
There are different strengths of this medicine, and depending on the disease, your doctor will prescribe tablets of the appropriate strength for you.
The recommended dose is:
Osteoarthritis
The recommended dose is 30 mg once daily, increased to a maximum of 60 mg once daily, if necessary.
Rheumatoid arthritis
The recommended dose is 60 mg once daily, increased to a maximum of 90 mg once daily, if necessary.
Ankylosing spondylitis.
The recommended dose is 60 mg once daily, increased to a maximum of 90 mg once daily, if necessary.
Acute pain conditions
Etoricoxib should only be used during episodes of acute pain.
Gout
The recommended dose is 120 mg once daily; it should only be used during episodes of acute pain, for a maximum of 8 days.
Pain after surgical dental procedures
The recommended dose is 90 mg once daily, and treatment with this dose may last for a maximum of 3 days.
Coxydyna should not be taken by children and adolescents under 16 years of age.
No dose adjustment is necessary for elderly patients. As with other medicines, elderly patients should be cautious.
Method of administration
Coxydyna is intended for oral use. The tablets should be taken once daily.
Coxydyna can be taken with or without food.
Never take more tablets than your doctor has prescribed. If you have taken too many Coxydyna tablets, seek medical attention immediately.
Coxydyna should be taken as directed by your doctor. If you miss a dose, the next day you should return to your usual dosing schedule. Do not take a double dose to make up for the missed dose.
If you have any further doubts about taking this medicine, consult your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Frequency of possible side effects is classified as follows:
Very common (affects more than 1 in 10 people)
Common (affects 1 to 10 in 100 people)
Uncommon (affects 1 to 10 in 1,000 people)
Rare (affects 1 to 10 in 10,000 people)
Very rare (affects less than 1 in 10,000 people)
The following side effects may occur during treatment with Coxydyna:
Very common
Common
Uncommon
Rare
If you experience any side effects, including any side effects not listed in this leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
By reporting side effects, you can help gather more information on the safety of this medicine.
Side effects can also be reported to the marketing authorization holder.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the carton after: EXP. The expiry date refers to the last day of the month stated.
Store in the original packaging to protect from moisture.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
carmellose sodium, magnesium stearate (E 470b).
Tablet coating:polyvinyl alcohol (E 1203), titanium dioxide (E 171), glycerol monostearate (E 471), indigo carmine (E 132), aluminum lake [only for 30 mg, 60 mg, and 120 mg], yellow iron oxide (E 172) [only 30 mg, 60 mg, and 120 mg], talc (E 553b), sodium lauryl sulfate.
Coated tablets.
Coxydyna, 30 mg, coated tablets
Blue-green, biconvex, coated tablet in the shape of an apple, with the inscription "30" on one side and smooth on the other, measuring 5.8 x 5.9 mm ± 7.5%.
Coxydyna, 60 mg, coated tablets
Dark green, biconvex, coated tablet in the shape of an apple, with the inscription "60" on one side and smooth on the other, measuring 7.1 x 7.3 mm ± 7.5%.
Coxydyna, 90 mg, coated tablets
White, biconvex, coated tablet in the shape of an apple, with the inscription "90" on one side and smooth on the other, measuring 8.1 x 8.3 mm ± 7.5%.
Coxydyna, 120 mg, coated tablets
Light green, biconvex, coated tablet in the shape of an apple, with the inscription "120" on one side and smooth on the other, measuring 8.9 x 9.2 mm ± 7.5%.
Coxydyna coated tablets are supplied in blisters containing 7, 14, 20, 28, 30, 50, 98, and 100 coated tablets, in a cardboard box.
Not all pack sizes may be marketed.
Aurovitas Pharma Polska Sp. z o.o.
ul. Sokratesa 13D lokal 27
01-909 Warsaw
e-mail: medicalinformation@aurovitas.pl
Rontis Hellas Medical and Pharmaceutical Products S.A.
P.O. Box 3012 Larisa Industrial Area
41004 Larisa
Greece
For 30 mg, 60 mg, and 90 mg doses:
Generis Farmacêutica, S.A.
Rua João de Deus 19, Venda Nova
2700-487 Amadora
Portugal
Belgium
Etoricoxib AB 30 mg/60 mg/90 mg/120 mg film-coated tablets
Germany
Etoricoxib PUREN 30 mg/60 mg/90 mg/120 mg film-coated tablets
France
Etoricoxib Arrow 30 mg/60 mg coated tablets
Netherlands
Etoricoxib Aurobindo 30 mg/60 mg/90 mg/120 mg film-coated tablets
Poland
Coxydyna
Portugal
Etoricoxib Generis
Romania
Etoricoxib Aurobindo 30 mg/60 mg/90 mg/120 mg film-coated tablets
Spain
Etoricoxib Aurobindo 30 mg/60 mg/90 mg/120 mg film-coated tablets EFG
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.